The first batch of purchasing coins netted 14 million Hong Kong dollars, with IVD MEDICAL (01931) being "Asia's first Ethereum treasury" too advanced.

On August 8, 2025, the price of Ether (ETH) closed at $4008.96, hitting a new high for the year. The Hong Kong stock company IVD MEDICAL (01931) purchased the first batch of 5190 ETH coins at a price of only $3661 per coin, resulting in a one-day profit of $1.8059 million (approximately HK$14.1764 million). This accurate bottom fishing became a "stroke of genius" for its launch of the "First Asian Ether Vault" strategy. The price of Ether (ETH) continued to rise on August 9, source: Golden Finance Earlier, IVD MEDICAL issued a profit warning, expecting the first half of 2025 to achieve a profit attributable to the parent company's owner of no less than 33 million yuan, compared to 125 million yuan in the same period last year. Now, with the "Global Enhanced Ether Vault" strategy, the company is expected to significantly improve its future financial performance. I. Three-pronged approach: Vault strategy, HashKey cooperation, and ETH Holding increase On August 8, IVD MEDICAL issued three announcements outlining its transition from a traditional medical leader to a Web3 financial hub: 1. Launch of the "Global Enhanced Ether Vault" Strategy IVD MEDICAL announced that Ether (ETH) would be used as a core reserve asset, aiming to create the "largest Ether Vault in Asia." Its business model is dual-driven: Ether (ETH) reserve vault: through own funds, profit distribution, asset swapping, and equity financing (ATM mechanism), continuously invest in and hold Ether (ETH); Ether (ETH) creation engine: leveraging the Web3 exchange ivd.xyz, tokenizing medical innovation drug intellectual property rights (RWA), exchanging trading revenue into Ether (ETH), forming a closed loop of "IP acquisition tokenization Ether (ETH) conversion vault enhancement". 2. Collaboration with HashKey Group: Key step towards compliance According to the agreement, HashKey Group will provide IVD MEDICAL with bulk trading execution and cost optimization for Ether (ETH), global market liquidity support, and explore the fusion path of encrypted asset reserves with real economic assets (especially medical innovation drug intellectual property RWA). By leveraging HashKey Group's full licensing compliance ecosystem (covering China, Hong Kong, Singapore, Bermuda), IVD MEDICAL obtains a "pass" to securely enter Web3. 3. Lightning purchase of 5,190 ETH coins, anchoring ambition of a trillion-dollar market cap The initial allocation of $149 million in ETH is just the beginning. The board of directors has authorized the future use of an additional $880 million to continue increasing holdings, aiming to become the leader in ETH reserves in the Hong Kong and even global stock market.